Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00635
|
|||||
| Drug Name |
Oxytetracycline
|
|||||
| Synonyms |
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; (2E,4S,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 5-Hydroxytetracycline; Adamycin; Antibiotic TM 25; Biostat; Biostat PA; Dabicycline; Dalimycin; Fanterrin; Geomycin; Geomycin (Streptomyces vimosus); Geotilin; Hydroxytetracycline; Imperacin; LA 200; Lenocycline; Liquamycin LA 200; Macocyn; Mycoshield TMQTHC 20; OTC; OTC (antibiotic); Oksisyklin; Ossitetraciclina; Ossitetraciclina [DCIT]; Oxacycline; Oxitetraciclina; Oxitetraciclina [INN-Spanish]; Oxitetracyclin; Oxitetracycline; Oxitetracyclinum; Oxymycin; Oxymykoin; Oxypam; Oxyterracin; Oxyterracine; Oxyterracyne;Oxytetracid; Oxytetracyclin; Oxytetracycline (anhydrous); Oxytetracycline (internal use); Oxytetracycline HCl; Oxytetracycline [INN]; Oxytetracycline amphoteric; Oxytetracycline anhydrous; Oxytetracycline calcium; Oxytetracyclinum; Oxytetracyclinum [INN-Latin]; Pennox 200; Proteroxyna; Riomitsin; Ryomycin; Solkaciclina; TM 5; Tarocyn; Tarosin; Teravit; Terrafungine; Terramitsin; Terramycin; Terramycin Q50; Terramycin im; Terramycin, Liquamycin, Oxytetracycline; Tetran; Unimycin; Ursocyclin; Ursocycline; Vendarcin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H24N2O9
|
|||||
| Canonical SMILES |
CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O
|
|||||
| InChI |
InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1
|
|||||
| InChIKey |
OWFJMIVZYSDULZ-PXOLEDIWSA-N
|
|||||
| CAS Number |
CAS 79-57-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 460.4 | Topological Polar Surface Area | 202 | ||
| Heavy Atom Count | 33 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 7 | Hydrogen Bond Acceptor Count | 10 | |||
| XLogP |
-1.6
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:27701
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.